HEXO · Hexo Corp

-

Please sign in to comment on HEXO

1 Comment

Admin

4 years ago

HEXO Corp is currently in a long term downtrend where the price is trading 8.1% below its 200 day moving average.

From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.5.

HEXO Corp's total revenue rose by 4.4% to $33M since the same quarter in the previous year.

Its net income has increased by 94.2% to $-21M since the same quarter in the previous year.

Finally, its free cash flow grew by 83.4% to $-13M since the same quarter in the previous year.

Based on the above factors, HEXO Corp gets an overall score of 4/5.

Exchange	NASDAQ
CurrencyCode	USD
ISIN	CA4283043079
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

PE Ratio	None
Target Price	1.39
Market Cap	31M
Dividend Yield	0.0%
Beta	2.13

ABOUT

Hexo Corp

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

HEXO · Hexo Corp

-

Hexo Corp

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Hexo Corp using a moving average strategy